Channel Insider

AUGUST 29, 2024

Cybersecurity giant Check Point Software has announced plans to acquire Cyberint Technologies , a leader in external risk management. The deal is expected to significantly enhance Check Point’s Security Operations Center (SOC) capabilities and expand its managed threat intelligence offerings. The acquisition comes on the heels of a significant leadership change.

Risk mitigation 105

Risk mitigation Collaboration 105

Mindmatrix

AUGUST 29, 2024

In today’s competitive business landscape, channel partnerships have emerged as a crucial strategy for driving growth and expanding market reach. As companies vie for dominance in each market segment of their respective industries, leveraging channel partnerships can offer significant advantages, such as accessing new customer segments, enhancing product offerings, and optimizing resource utilization.

Co-Alliance 52

Co-Alliance Channels and alliances Strategic alliances Retail 52

Frost & Sullivan

AUGUST 29, 2024

Sustained growth in nutrition and wellness now hinges on the ability of companies to leverage emerging ingredients and technologies. Be it agrochemical solutions or wellness segments like hair care and nutraceuticals, this ecosystem is witnessing competitive intensity, rising demand, and a growing emphasis on sustainability and digitalization. The landscape is rich with opportunities, making this an exciting time for innovation and expansion.

Ecosystems 52

Ecosystems Collaboration 52

TRG Blog

AUGUST 29, 2024

As the economy evolves rapidly, building an adaptable workforce is crucial for organisations seeking to stay ahead of change. Yet true talent acquisition requires more than filling vacancies; it demands a holistic approach that encompasses both current and future hiring needs.

52

52

Advertiser: ZoomInfo

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

Frost & Sullivan

AUGUST 29, 2024

By Benson Augustine, Program Manager – Mobility The Latin American brake replacement market for passenger cars and light commercial vehicles is undergoing significant transformation, driven by changing consumer preferences and intensified competition from low-cost imports. As the market landscape evolves, domestic brake products are expected to maintain a competitive edge through differentiation in positioning and brand identity, despite the increasing market pressures.

52

52

Frost & Sullivan

AUGUST 29, 2024

Transforming Digital Infrastructure with the Data Center Revolution Data center colocation services in India are experiencing a series of changes fuelled by the rising demand for robust data storage and processing from hyperscale cloud providers, over-the-top (OTT) platforms, content providers, and artificial intelligence (AI) companies. This shift is accelerated by advancements in 5G, Internet of Things (IoT), the proliferation of smartphones, and favourable government policies.

Energy 52

Energy Ecosystems Government Partnership strategies 52

Channel Insider

AUGUST 29, 2024

Earlier in August, international IT solutions provider Fulcrum IT Partners announced it was acquiring Fortress and adding its capabilities , including its 24/7 U.S.-based SOC offering, into the Fulcrum portfolio of products and services. The acquisition is the latest in a series of purchases for the massive services provider, which has acquired several MSPs over the past several years to form one company with a variety of niche expertise and locations in the US and Canada as well as throughout E

Utilities 105

Utilities 105

Frost & Sullivan

AUGUST 29, 2024

As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% increase from 2022. However, the pharma/biopharma industry overall shows stagnant R&D activity. Total R&D expenditure is approximately $276.81 billion, with a modest 2.5% growth from 2023 to 2024. The Pharma industry is facing a declining average return on investment (ROI) for R&D, dropping to 1.2%, and peak sales per asset hovering just above $350

Biopharma 52

Biopharma Biotechnology Contract research organization Utilities 52